Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Veit

Showing results (171-180 of 236) with videos related to

Pageof 24
Sort By:
European Radiology|July 10, 2012
Combined PET/CT-perfusion in patients with head and neck cancersPatrick Veit-Haibach, Daniel Schmid, Klaus Strobel, et al.
BMC Medical Imaging|December 31, 2015
Combined PET/CT-perfusion in patients with head and neck cancers might predict failure after radio-chemotherapy: a proof of concept studyCarsten Pietsch, Felipe de Galiza Barbosa, Martin W Hüllner, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|June 8, 2025
Prognostic value of early post-treatment <sup>18</sup>F-FDG PET/CT in diffuse large B-cell lymphoma patients receiving chimeric antigen receptor T-cell therapySeyed Ali Mirshahvalad, Andres Kohan, Roshini Kulanthaivelu, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 25, 2019
Summary of the First ISMRM-SNMMI Workshop on PET/MRI: Applications and LimitationsThomas A Hope, Zahi A Fayad, Kathryn J Fowler, et al.
Head & Neck|November 10, 2019
Evaluation of 18F-FDG PET/CT as an early imaging biomarker for response monitoring after radiochemotherapy using cetuximab in head and heck squamous cell carcinomaFelipe de Galiza Barbosa, Oliver Riesterer, Stephanie Tanadini-Lang, et al.
Cancers|May 25, 2024
The [<sup>18</sup>F]F-FDG PET/CT Radiomics Classifier of Histologic Subtypes and Anatomical Disease Origins across Various Malignancies: A Proof-of-Principle StudyRicarda Hinzpeter, Seyed Ali Mirshahvalad, Vanessa Murad, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 19, 2013
Protocol requirements and diagnostic value of PET/MR imaging for liver metastasis detectionCaecilia S Reiner, Paul Stolzmann, Lars Husmann, et al.
Academic Radiology|July 13, 2024
Predictive [<sup>18</sup>F]-FDG PET/CT-Based Radiogenomics Modelling of Driver Gene Mutations in Non-small Cell Lung CancerRicarda Hinzpeter, Roshini Kulanthaivelu, Andres Kohan, et al.
Clinical Nuclear Medicine|May 22, 2024
Comparison of Multiparametric MRI and the Combination of PSMA Plus MRI for the Intraprostatic Diagnosis of Prostate Cancer: A Systematic Review and Meta-AnalysisGiovanni Brondani Torri, Pedro Antune Pereira, Camila Piovesan Wiethan, et al.
Radiology|August 8, 2014
Whole-body nonenhanced PET/MR versus PET/CT in the staging and restaging of cancers: preliminary observationsMartin W Huellner, Philippe Appenzeller, Félix P Kuhn, et al.
Pageof 24

Showing results (171-180 of 236) with videos related to

Sort By:
Pageof 24
European Radiology|July 10, 2012
Combined PET/CT-perfusion in patients with head and neck cancersPatrick Veit-Haibach, Daniel Schmid, Klaus Strobel, et al.
BMC Medical Imaging|December 31, 2015
Combined PET/CT-perfusion in patients with head and neck cancers might predict failure after radio-chemotherapy: a proof of concept studyCarsten Pietsch, Felipe de Galiza Barbosa, Martin W Hüllner, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|June 8, 2025
Prognostic value of early post-treatment <sup>18</sup>F-FDG PET/CT in diffuse large B-cell lymphoma patients receiving chimeric antigen receptor T-cell therapySeyed Ali Mirshahvalad, Andres Kohan, Roshini Kulanthaivelu, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 25, 2019
Summary of the First ISMRM-SNMMI Workshop on PET/MRI: Applications and LimitationsThomas A Hope, Zahi A Fayad, Kathryn J Fowler, et al.
Head & Neck|November 10, 2019
Evaluation of 18F-FDG PET/CT as an early imaging biomarker for response monitoring after radiochemotherapy using cetuximab in head and heck squamous cell carcinomaFelipe de Galiza Barbosa, Oliver Riesterer, Stephanie Tanadini-Lang, et al.
Cancers|May 25, 2024
The [<sup>18</sup>F]F-FDG PET/CT Radiomics Classifier of Histologic Subtypes and Anatomical Disease Origins across Various Malignancies: A Proof-of-Principle StudyRicarda Hinzpeter, Seyed Ali Mirshahvalad, Vanessa Murad, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 19, 2013
Protocol requirements and diagnostic value of PET/MR imaging for liver metastasis detectionCaecilia S Reiner, Paul Stolzmann, Lars Husmann, et al.
Academic Radiology|July 13, 2024
Predictive [<sup>18</sup>F]-FDG PET/CT-Based Radiogenomics Modelling of Driver Gene Mutations in Non-small Cell Lung CancerRicarda Hinzpeter, Roshini Kulanthaivelu, Andres Kohan, et al.
Clinical Nuclear Medicine|May 22, 2024
Comparison of Multiparametric MRI and the Combination of PSMA Plus MRI for the Intraprostatic Diagnosis of Prostate Cancer: A Systematic Review and Meta-AnalysisGiovanni Brondani Torri, Pedro Antune Pereira, Camila Piovesan Wiethan, et al.
Radiology|August 8, 2014
Whole-body nonenhanced PET/MR versus PET/CT in the staging and restaging of cancers: preliminary observationsMartin W Huellner, Philippe Appenzeller, Félix P Kuhn, et al.
Pageof 24